Russia Air Transport Agency not to comment on MH17 crash probe before Dutch report
Ukraine continues tanks withdrawal in Luhansk region territories under its control
Foreign Ministry: No volunteers recruited in Russia to fight in Syria
Russia, India ponder co-development of new generation infantry fighting vehicle — company
Chechen leader says ready to be questioned over murder of Russian opposition figure
Ukraine continues tanks withdrawal in Luhansk region territories under its controlWorld October 06, 19:03
Belarusians face task to keep country when world is being repartitioned — presidentWorld October 06, 18:54
Foreign Ministry: No volunteers recruited in Russia to fight in SyriaRussian Politics & Diplomacy October 06, 18:45
Gazprom confirms plans to construct only two lines of Turkish StreamBusiness & Economy October 06, 18:38
Ukraine’s total debt exceeds $70.5 blnBusiness & Economy October 06, 18:29
MP: Election postponement demonstrates Donbas commitment to Minsk accordsWorld October 06, 17:57
Chechen head Kadyrov presents strand of Prophet Muhammad’s hair to Moscow mosqueSociety & Culture October 06, 17:51
Russian Defense Ministry disproves media reports about Russian airstrikes in PalmiraMilitary & Defense October 06, 17:47
Demand for gas in Europe to go down till 2020 — Head of State Duma energy committeeBusiness & Economy October 06, 16:59
NOVOSIBIRSK, October 30 (Itar-Tass) - Scientists of the Institute of Clinical Immunology in the Siberian branch of the Russian Academy of Medical Sciences in Novosibirsk have developed a vaccine for the treatment of cancer, the institute's director, Professor Vladimir Kozlov, told Itar-Tass on Wednesday.
The vaccine has already successfully passed clinical tests. Currently, it is being given to patients by injection at the third and fourth stages of cancer and is reported as having increased patient lifespan more than twofold.
“We are deriving dendritic cells from the human body and loading them with tumor antigens," the scientist said. "Dendritic cells process them, then we inject the cells into the patient and they start working in the body evoking a strong immune response. That is, they are actively fighting the tumor."
The institute's creation "is not a classical vaccine, which is the means to prevent the illness", Professor Kozlov said. "In fact, it is cell therapy.”
The vaccine is counteracting several types of cancer - colorectal (bowel) cancer, breast cancer and prostate cancer - and the institute is ready to start its industrial production, Kozlov added.
He warned, however, that “one should not seek a panacea for malign tumors as they cannot be overcome with only one tool. Along with dendritic cells, there are other cells that fight cancer so all means are to be applied in complex. An immunomodulating cocktail is needed for a far-reaching effect,” Kozlov said.
Other types of therapy were to be used as well, such as chemotherapy and radiation therapy, the professor said. Treatment should vary case by case, he said, adding that the institute was already developing preventive vaccines against other illnesses, atherosclerosis among them, and that they would be presented soon.